Group 1 - The core point of the announcement is that Baiyang Pharmaceutical plans to introduce Zap Therapeutic Solutions Limited to invest $4.9 million in Baiyang Sap Medical Equipment Technology Co., Ltd. to enhance its capital strength and meet operational development needs [1][2] - Baiyang Sap is a wholly-owned subsidiary of Baiyang Health Industry International Trade Co., Ltd., which is fully owned by Baiyang Pharmaceutical [1] - The investment aims to support the localization of the ZAP-X radiotherapy robot, enhancing production capacity and facilitating the commercialization of ZAP-X in clinical settings [2] Group 2 - Baiyang Pharmaceutical intends to expand its product layout in the innovative medical device sector and promote resource integration and collaborative development through investments in Zap Medical System, Ltd. starting from July 2024 [2] - The collaboration will include exclusive commercialization and manufacturing services for ZAP-X, which is expected to enrich the company's industrial layout in innovative devices and increase revenue and profitability from innovative products [2]
百洋医药子公司百洋萨普拟引入Zap Therapeutic增资490万美元